FDA recalls over 89K bottles of nasal spray that may cause ‘adverse’ medical effects ...
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Don’t use this nasal spray: FDA says it may cause ‘adverse’ effects
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
Healthline1 个月
Migraine Nasal Sprays Explained
A doctor may prescribe ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if ...
Rolling Out24 天
Alzheimer’s new nasal spray stops memory loss
The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...
Pharmabiz13 天
New norms for nasal spray of ASU drugs to bring in uniformity in composition & efficacy ...
Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...
WebMD23 天
What to Know About the New Nasal Spray for Tough Depression
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
New York Post25 天
Can a nasal spray cure loneliness? Effects of hormone spritz lasted for months in study
The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...
Newsweek27 天
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Gizmodo28 天
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Medscape26 天
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to be used as a standalone treatment in ...
UPI28 天
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
U.S. News & World Report27 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...